James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $539.64 ($5.5M) on 2026-06-04, disclosed to the SEC on 2026-06-05.
Scheduled sale ($5.5M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $539.64 | 120 | $65K | 1.2% |
| 2 | $541.14 | 480 | $260K | 4.8% |
| 3 | $542.78 | 440 | $239K | 4.4% |
| 4 | $544.11 | 1,086 | $591K | 10.8% |
| 5 | $544.94 | 1,545 | $842K | 15.4% |
| 6 | $545.89 | 1,129 |
| $616K |
| 11.3% |
| 7 | $547.00 | 1,033 | $565K | 10.3% |
| 8 | $548.04 | 2,749 | $1.5M | 27.6% |
| 9 | $549.06 | 1,298 | $713K | 13.0% |
| 10 | $550.48 | 120 | $66K | 1.2% |
| Total | $546.28 avg | 10,000 | $5.5M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |